Dermapharm Holding SE
DMP | F
Overview
Corporate Details
- ISIN(s):
- DE000A2GS5D8
- LEI:
- 5299009F0KNZINQQQK37
- Country:
- Germany
- Address:
- Lil-Dagover-Ring 7, 82031 Grünwald
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Dermapharm is a rapidly growing manufacturer of branded pharmaceuticals. Founded in 1991, the Company is based in Grünwald near Munich. The Company's integrated business model comprises in-house development, production and the distribution of brand products by a trained pharmaceutical sales force. In addition to its main location in Brehna near Leipzig, Dermapharm also operates other production, development and distribution locations in Europe (primarily in Germany) and the United States. In the "Branded pharmaceuticals and other healthcare products" segment, Dermapharm has approximately 1,300 marketing authorisations with more than 380 active pharmaceutical ingredients. Dermapharm's portfolio of pharmaceuticals, medical devices and food supplements are tailored to selected therapeutic areas in which the Company is a market leader, especially in Germany.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-05 12:29 |
Directors' Dealings
Dermapharm Holding SE: Anja Schorn, buy
|
English | 6.2 KB | |
| 2025-06-04 11:19 |
Directors' Dealings
Dermapharm Holding SE: Dr. Hans-Georg Feldmeier, buy
|
English | 6.9 KB | |
| 2025-05-16 15:05 |
General Meeting Notice
Dermapharm Holding SE: Bekanntmachung der Einberufung zur Hauptversammlung am 2…
|
German | 59.4 KB | |
| 2025-05-15 07:30 |
Earnings Release
Dermapharm Holding SE performs in line with projections in Q1 2025, confirms fu…
|
English | 23.6 KB | |
| 2025-05-15 00:00 |
Quarterly Report
Q1 statement / Q1 financial report 2025
|
English | 347.5 KB | |
| 2025-05-07 08:40 |
Report Publication Announcement
|
English | 3.9 KB | |
| 2025-04-14 15:08 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 12.1 KB | |
| 2025-04-08 16:44 |
Directors' Dealings
Dermapharm Holding SE: Susanne Gertrud Pia Lanz, buy
|
English | 6.4 KB | |
| 2025-03-28 07:30 |
Earnings Release
Successful financial year 2024: Dermapharm increases revenue and exceeds EBITDA…
|
English | 26.5 KB | |
| 2025-03-28 00:00 |
Regulatory News Service
Annual financial report 2024
|
English | 4.3 MB | |
| 2025-03-21 10:36 |
Report Publication Announcement
|
English | 4.0 KB | |
| 2025-03-20 17:15 |
Declaration of Voting Results & Voting Rights Announcements
|
German | 12.3 KB | |
| 2025-03-19 17:15 |
Declaration of Voting Results & Voting Rights Announcements
|
German | 12.3 KB | |
| 2025-03-19 13:13 |
Directors' Dealings
Dermapharm Holding SE: Themis Beteiligungs-Aktiengesellschaft, buy
|
English | 6.0 KB | |
| 2025-03-18 13:13 |
Directors' Dealings
Dermapharm Holding SE: Themis Beteiligungs-Aktiengesellschaft, buy
|
English | 6.0 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-04-04 | Dreibholz, Katharina | Close relation | Buy | None | 449.04 EUR |
| 2023-04-04 | Dreibholz, Benjamin | Close relation | Buy | None | 449.28 EUR |
| 2023-04-03 | Dreibholz, Christof | Board | Buy | None | 49,024.00 EUR |
| 2023-01-13 | NEON Equity AG | Close relation | Buy | None | 16,897.00 EUR |
| 2023-01-11 | Dreibholz, Christof | Board | Buy | None | 49,638.00 EUR |
| 2022-10-17 | Weidenmann, Ralph | Supervisory board | Buy | None | 2,638.25 EUR |
| 2022-10-17 | Riedel, Oliver | Board | Buy | None | 11,013.18 EUR |
| 2022-10-17 | Riedel, Oliver | Board | Buy | None | 8,650.00 EUR |
| 2022-10-14 | Feldmeier, Dr. Hans-Georg | Board | Buy | None | 98,900.00 EUR |
| 2022-10-13 | Themis Beteiligungs-Aktiengesellschaft | Close relation | Buy | None | 55,825,000.00 EUR |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
|
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
|
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
| Alma Yesodot Ltd. | Israel | KVSR | ||
|
Antibiotice S.A. | Romania | ATB | |
|
Aran Research & Development (1982) Ltd. | Israel | ARAN | |
|
Asarina Pharma AB | Sweden | ASAP |